Internal Medicine, Hematology & Oncology · Abilene, TX
NPI
1801834544
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1100 N 19th St, Suite 1a
Abilene, TX, 79601
Phone (325) 672-4368
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
249,893 services
Medicare patients, 2024
783
Average age 75
Drug cost, 2024
$2.9M
2,236 prescriptions
Company payments, 2025
$5,340
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anton M Melnyk Jr. was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 68,340 times for 71 patients. In total Anton M Melnyk Jr. billed 249,893 services in 177 codes, and Medicare paid $3.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-10.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 68,340 | 71 | $0.28 | $19K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 18,398 | 143 | $0.10 | $1,835 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 16,700 | 15 | $0.06 | $937 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 15,700 | 23 | $44.49 | $698K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 11,797 | 13 | $2.29 | $27K |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 8,340 | 11 | $0.36 | $3,011 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,475 | 77 | $0.09 | $219 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 1,660 | 13 | $35.15 | $58K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,400 | 14 | $16.37 | $23K |
| 36415 Venipuncture Blood Collection | Office | 1,391 | 427 | $8.63 | $12K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,300 | 37 | $0.25 | $327 |
| 80053 Clinical Chemistry | Office | 1,276 | 422 | $10.31 | $13K |
| 85025 Blood Count | Office | 1,253 | 413 | $7.58 | $9,495 |
| 99213 Office E&M - Established | Office | 1,208 | 422 | $60.82 | $73K |
| J9190 Injection, fluorouracil, 500 mg | Office | 677 | 19 | $2.28 | $1,544 |
By year: 2022 $3.8M for 241,261 services; 2023 $3.3M for 269,536 services; 2024 $3.0M for 249,893 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,391 | 427 | $8.63 | $12K |
| 80053 Clinical Chemistry | 1,276 | 422 | $10.31 | $13K |
| 85025 Blood Count | 1,253 | 413 | $7.58 | $9,495 |
| 82378 Clinical Chemistry | 375 | 174 | $18.44 | $6,916 |
| 86300 Immunoassay | 320 | 150 | $20.21 | $6,468 |
| 83615 Clinical Chemistry | 188 | 104 | $5.92 | $1,113 |
| 83735 Clinical Chemistry | 135 | 45 | $6.57 | $887 |
| 85027 Blood Count | 126 | 51 | $6.34 | $799 |
| 85007 Blood Count | 126 | 51 | $3.72 | $469 |
| 85055 Blood Count | 93 | 43 | $34.35 | $3,194 |
Medicare prescription drug claims, 2024
In 2024, the drug Anton M Melnyk Jr. prescribed most often to Medicare patients was Anastrozole, with 385 prescriptions and refills. In total Anton M Melnyk Jr. wrote 2,236 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 385 | 759 | 89 | $4,621 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 150 | 150 | 39 | $5,107 |
| Ondansetron Hcl Generic | 115 | 115 | 50 | $657 |
| Tamoxifen Citrate Generic | 107 | 189 | 24 | $2,266 |
| Potassium Chloride Generic | 66 | 103 | 21 | $898 |
| Levothyroxine Sodium Generic | 66 | 104 | 11 | $1,599 |
| Fentanyl Generic | 63 | 63 | 16 | $6,052 |
| Prednisone Generic | 60 | 65 | 19 | $581 |
| Promethazine Hcl Generic | 48 | 48 | 24 | $294 |
| Acyclovir Generic | 44 | 53 | Under 11 | $335 |
| Furosemide Generic | 43 | 65 | 14 | $139 |
| Gabapentin Generic | 42 | 56 | 13 | $391 |
| Eliquis Apixaban | 38 | 42 | Under 11 | $24K |
| Tramadol Hcl Generic | 38 | 38 | 17 | $396 |
| Alprazolam Generic | 36 | 36 | Under 11 | $422 |
Brand drugs: - claims; generic drugs: 1,970 claims; opioid claims: 279.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anton M Melnyk Jr. $5,340 ($5,340 in general payments such as food, travel and fees) from 36 companies. The largest payer was Janssen Global Services, LLC with $1,980.
| Company | Payments | Amount |
|---|---|---|
| Janssen Global Services, LLC JNJ | 1 | $1,980 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $1,434 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $222 |
| Geron Corporation GERN | 3 | $157 |
| Gilead Sciences, Inc. GILD | 4 | $155 |
| Abbvie Inc. ABBV | 3 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $135 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $110 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $105 |
| Daiichi Sankyo Inc. 4568.T | 1 | $93.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.